Archer-Daniels-Midland vs Pfizer Inc.
Side-by-side earnings signal comparison from SEC quarterly filings
Verdict
Archer-Daniels-Midland (ADM) carries a "Neutral" signal with +2.8% revenue growth, while Pfizer Inc. (PFE) is "Neutral" with -18.4% revenue growth. Both companies report in the Consumer Staples and Healthcare sectors.
| Metric | Archer-Daniels-Midland (ADM) | Pfizer Inc. (PFE) |
|---|---|---|
| Operator Signal | Neutral | Neutral |
| Signal Confidence | HIGH | HIGH |
| Latest Revenue | $20.5B | $14.5B |
| Revenue Growth | 2.8%* | -18.4% |
| Latest EPS | $0.62* | $0.47 |
| EPS Growth | 1450.0%* | -39.7% |
| Sector | Consumer Staples | Healthcare |
| Quarters Tracked | 8 | 8 |
Archer-Daniels-Midland (ADM) carries a "Neutral" signal with +2.8% revenue growth, while Pfizer Inc. (PFE) is "Neutral" with -18.4% revenue growth. Both companies report in the Consumer Staples and Healthcare sectors.